Similar articles

• The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.

  Pellegrini A, Guiñazu N, Giordanengo L, Cano RC, Gea S. Pellegrini A, et al. Future Microbiol. 2011 Dec;6(12):1521-33. doi: 10.2217/fmb.11.122. Future Microbiol. 2011. PMID: 22122446 Review.
• Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles.

  Cestari I, Ansa-Addo E, Deolindo P, Inal JM, Ramirez MI. Cestari I, et al. J Immunol. 2012 Feb 15;188(4):1942-52. doi: 10.4049/jimmunol.1102053. Epub 2012 Jan 18. J Immunol. 2012. PMID: 22262654
• Immune system recognition of Trypanosoma cruzi.

  Tarleton RL. Tarleton RL. Curr Opin Immunol. 2007 Aug;19(4):430-4. doi: 10.1016/j.coi.2007.06.003. Epub 2007 Jul 24. Curr Opin Immunol. 2007. PMID: 17651955 Review.
• Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.

  DosReis GA. DosReis GA. Braz J Med Biol Res. 2011 Feb;44(2):84-90. doi: 10.1590/s0100-879x2011007500005. Epub 2011 Jan 14. Braz J Med Biol Res. 2011. PMID: 21243314 Review.
• Innate and acquired immunity in the pathogenesis of Chagas disease.

  Golgher D, Gazzinelli RT. Golgher D, et al. Autoimmunity. 2004 Aug;37(5):399-409. doi: 10.1080/08916930410001713115. Autoimmunity. 2004. PMID: 15621564 Review.